Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

APVO Aptevo Therapeutics Inc

0,7422

0,0167 (2,30%)

01 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Aptevo Therapeutics (NASDAQ:APVO)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Aptevo Therapeutics Charts.

Aptevo Therapeutics (NASDAQ:APVO)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Aptevo Therapeutics Charts.

News Aptevo Therapeutics Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 6 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 31 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form DEFR14A - Revised definitive proxy soliciting materials
Dienstag 30 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form DEFR14A - Revised definitive proxy soliciting materials
Dienstag 16 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Aptevo Therapeutics Inc News-Artikel

Slam Exploration

Purpose Canadian Financi...

Societe Generale Effekten

Pegazus Finance

Fidelity Nasdaq Composit...

Euronext S Bouygues 0303...

Bite Acquisition

Iovance Biotherapeutics

Emerald Strategic Innova...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen